.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 478
N° Accessi Relaz.: 168922

2nd Biennial Schizophrenia International Research Conference

Palazzo Congressi (FI)
10/04/2010 - 14/04/2010

	Relazioni: 18
	Programma Evento
	Foto: 5
	Info

Mostra tutti | Mostra contenuti EasyRec

A. George Awad
Subjective Tolerability to Antipsychotics in Schizophrenia, Over 30 Years of Research: Are We on the Verge of a New Science of "Subjective Tolerability Disorders"

Akira Sawa
Moving from gene to function in mutant model of schizophrenia

Alain Dagher
The Role of Environmental Factors

Alessandro Bertolino
Use of intermediate phenotypes in pharmacogenetics

Alessandro Bertolino
.

Alessandro Guidotti
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

Alessandro Serretti
Methods for obtaining clinically useful pharmacogenetic predictors; An example of a detailed investigation in an haloperidol treated sample

Alex Hofer
Social Cognition

Amanda Law
ErbB4 and PI3KCD and are Interacting Biological and Genetic Factors That Regulate NRG1-mediated PI3K Signaling and Risk for Schizophrenia.

Andreas Meyer-Lindenberg

Andreas Meyer-Lindenberg
Mechanisms of GEI in schizophrenia

Andrew Thompson
Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodromal Longitudinal Study

Anil Malhotra
Pharmacogenomic approaches to rare and common side effects associated with antipsychotic drug treatment

Anissa Abi-Dargham
Linking dopamine dysregulation to symptoms and clinical phase brain imaging studies

Anthony Grace
The neurodevelopmental perspective: Dopamine system overdrive by the hippocampus in an animal model of schizophrenia and reversal by antipsychotic drugs